Tilray Inc (NASDAQ:TLRY - Get Free Report) shares rose 4% during trading on Friday . The company traded as high as $1.71 and last traded at $1.71. Approximately 7,497,567 shares traded hands during trading, a decline of 70% from the average daily volume of 25,026,160 shares. The stock had previously closed at $1.64.
Wall Street Analysts Forecast Growth
Separately, Roth Mkm reduced their price objective on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research report on Friday, October 11th.
Check Out Our Latest Stock Analysis on Tilray
Tilray Stock Up 3.0 %
The firm has a 50 day simple moving average of $1.71 and a two-hundred day simple moving average of $1.80. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -3.84 and a beta of 2.13. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The business had revenue of $200.00 million for the quarter, compared to analysts' expectations of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm's revenue was up 13.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) EPS. As a group, sell-side analysts expect that Tilray Inc will post -0.14 EPS for the current year.
Hedge Funds Weigh In On Tilray
A number of institutional investors have recently bought and sold shares of the business. Prospect Financial Services LLC acquired a new position in shares of Tilray in the second quarter valued at approximately $26,000. Signature Estate & Investment Advisors LLC bought a new stake in shares of Tilray in the second quarter valued at about $29,000. Jeppson Wealth Management LLC acquired a new position in shares of Tilray in the second quarter valued at about $33,000. Vanguard Capital Wealth Advisors bought a new position in Tilray during the second quarter worth about $34,000. Finally, HBK Sorce Advisory LLC acquired a new stake in Tilray in the 1st quarter worth about $37,000. Institutional investors and hedge funds own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
